Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma - Quiz - MDSpire

Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma

  • By

  • Malin Hultcrantz

  • Hani Hassoun

  • Neha Korde

  • Kylee MacLachlan

  • Sham Mailankody

  • Dhwani Patel

  • Urvi A. Shah

  • Carlyn Rose Tan

  • David J. Chung

  • Oscar B. Lahoud

  • Heather J. Landau

  • Michael Scordo

  • Gunjan L. Shah

  • Sergio A. Giralt

  • Matthew J. Pianko

  • Miranda Burge

  • Kelly Barnett

  • Meghan Salcedo

  • Julia Caple

  • Linh Tran

  • Jenna Blaslov

  • Tala Shekarkhand

  • Selena Hamid

  • David Nemirovsky

  • Andriy Derkach

  • Oluwatobi Arisa

  • Cody J. Peer

  • William D. Figg

  • Saad Z. Usmani

  • Ola Landgren

  • Alexander M. Lesokhin

  • September 19, 2024

  • 0 min

Share

Original Source(s)

Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma

  • by Malin Hultcrantz, Hani Hassoun, Neha Korde, Kylee MacLachlan, Sham Mailankody, Dhwani Patel, Urvi A. Shah, Carlyn Rose Tan, David J. Chung, Oscar B. Lahoud, Heather J. Landau, Michael Scordo, Gunjan L. Shah, Sergio A. Giralt, Matthew J. Pianko, Miranda Burge, Kelly Barnett, Meghan Salcedo, Julia Caple, Linh Tran, Jenna Blaslov, Tala Shekarkhand, Selena Hamid, David Nemirovsky, Andriy Derkach, Oluwatobi Arisa, Cody J. Peer, William D. Figg, Saad Z. Usmani, Ola Landgren, Alexander M. Lesokhin

  • September 19, 2024

Related Content

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study

CRISPR Enables In Vivo CAR T Cell Production

In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing

  • March 30, 2026

  • 2 min